Pfizer Inc.PFENYSE
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, slight contraction.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$9.84B
↓ 33% below average
Average (9y)
$14.69B
Historical baseline
Range
High:$29.87B
Low:$4.79B
CAGR
-3.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $9.84B | +105.2% |
| 2023 | $4.79B | -81.6% |
| 2022 | $26.03B | -12.8% |
| 2021 | $29.87B | +157.2% |
| 2020 | $11.61B | +16.2% |
| 2019 | $9.99B | -26.7% |
| 2018 | $13.63B | -4.4% |
| 2017 | $14.25B | +2.5% |
| 2016 | $13.90B | +6.8% |
| 2015 | $13.02B | - |